Overview and Highlights of the RESET Clinical Trial

In an interview with Pharmacy Times, Helen Thackray, MD from GlycoMimetics, Inc. gave a quick overview and highlights of her study, called “Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis," which was presented at the 62nd ASH Annual Meeting and Exposition.